Progesterone rapidly down-regulates the biosynthesis of 5-lipoxygenase products in human primary monocytes

Pharmacol Res. 2015 Apr:94:42-50. doi: 10.1016/j.phrs.2015.01.007. Epub 2015 Feb 11.

Abstract

5-Lipoxygenase (5-LO), the key enzyme in the biosynthesis of pro-inflammatory leukotrienes (LTs) from arachidonic acid, is regulated by androgens in human neutrophils and monocytes accounting for sex differences in LT formation. Here we show that progesterone suppresses the synthesis of 5-LO metabolites in human primary monocytes. 5-LO product formation in monocytes stimulated with Ca(2+)-ionophore A23187 or with lipopolysaccharide/formyl peptide was suppressed by progesterone at concentrations of 10-100 nM in cells from females and at 1 μM in cells from males. Progesterone down-regulated 5-LO product formation in a rapid and reversible manner, but did not significantly inhibit 5-LO activity in cell-free assays using monocyte homogenates. Also, arachidonic acid release and its metabolism to other eicosanoids in monocytes were not significantly reduced by progesterone. The inhibitory effect of progesterone on LTs was still observed when mitogen-activated protein kinases were pharmacologically blocked, stimulatory 1-oleoyl-2-acetyl-sn-glycerol was exogenously supplied, or extracellular Ca(2+) was removed by chelation. Instead, suppression of PKA by means of two different pharmacological approaches (i.e. H89 and a cell-permeable PKA inhibitor peptide) prevented inhibition of 5-LO product generation by progesterone, to a similar extent as observed for the PKA activators prostaglandin E2 and 8-Br-cAMP, suggesting the involvement of PKA. In summary, progesterone affects the capacity of human primary monocytes to generate 5-LO products and, in addition to androgens, may account for sex-specific effects on pro-inflammatory LTs.

Keywords: 1-Oleoyl-2-acetyl-sn-glycerol (OAG) (PubChem CID: 6437085); 5-Lipoxygenase; 8-Br-cAMP (PubChem CID: 32014); Arachidonic acid; Ca(2+)-ionophore A23187 (PubChem CID: 11957499); Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC) (PubChem CID: 14840979); H89 (PubChem CID: 449241); Leukotriene; Monocytes; Progesterone; Prostaglandin E(2) (PubChem CID: 5280360); Sex differences; cPLA(2)α inhibitor RSC-3388, N-{(2S,4R)-4-(biphenyl-2-ylmethyl-isobutyl-amino)-1-[2-(2,4-difluorobenzoyl)-benzoyl]-pyrrolidin-2-ylmethyl}-3-[4-(2,4-dioxothiazolidin-5-ylidenemethyl)-phenyl]acrylamide (PubChem CID: 9833099).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonate 5-Lipoxygenase / biosynthesis*
  • Arachidonic Acid / metabolism
  • Calcium / metabolism
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Down-Regulation / drug effects
  • Humans
  • Monocytes / drug effects
  • Monocytes / enzymology
  • Monocytes / metabolism*
  • Primary Cell Culture
  • Progesterone / pharmacology*
  • Signal Transduction

Substances

  • Arachidonic Acid
  • Progesterone
  • Arachidonate 5-Lipoxygenase
  • Cyclic AMP-Dependent Protein Kinases
  • Calcium